Synapse

← ISRN Oncology

Papers in ISRN Oncology

Page 2 · newest first

  1. Deregulations in the Cyclin-Dependent Kinase-9-Related Pathway in Cancer: Implications for Drug Discovery and DevelopmentISRN Oncology · 2013
  2. The Role of Chronic Inflammation in Obesity-Associated CancersISRN Oncology · 2013
  3. Neoadjuvant Treatment in Patients with HER2-Positive Breast CancerISRN Oncology · 2013
  4. Glioma Stem Cells and Immunotherapy for the Treatment of Malignant GliomasISRN Oncology · 2013
  5. Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer WomenISRN Oncology · 2013
  6. Endocytic Adaptor Protein Epsin Is Elevated in Prostate Cancer and Required for Cancer ProgressionISRN Oncology · 2013
  7. Expression and Regulation of 11-β Hydroxysteroid Dehydrogenase Type 2 Enzyme Activity in the Glucocorticoid-Sensitive CEM-C7 Human Leukemic Cell LineISRN Oncology · 2013
  8. Osteosarcoma in Adult Patients Living with HIV/AIDSISRN Oncology · 2013
  9. Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor InfiltrationISRN Oncology · 2013
  10. Gene Expression Profile Analysis of T1 and T2 Breast Cancer Reveals Different Activation PathwaysISRN Oncology · 2013
  11. ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine TumoursISRN Oncology · 2013
  12. Pathways to Breast Cancer RecurrenceISRN Oncology · 2013
  13. Decreasing Frequency of Osteonecrosis of the Jaw in Cancer and Myeloma Patients Treated with Bisphosphonates: The Experience of the Oncology Network of Piedmont and Aosta Valley (North-Western Italy)ISRN Oncology · 2013
  14. Vitamin D: Are We Ready to Supplement for Breast Cancer Prevention and Treatment?ISRN Oncology · 2013
  15. Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?ISRN Oncology · 2013
  16. Diabetes and Risk of CancerISRN Oncology · 2013
  17. Epigenetic Influences in the Aetiology of Cancers Arising from Breast and Prostate: A Hypothesised Transgenerational Evolution in Chromatin AccessibilityISRN Oncology · 2013
  18. Does Changeover by an Experienced Open Prostatic Surgeon from Open Retropubic to Robot-Assisted Laparoscopic Prostatectomy Mean a Step Forward or Backward?ISRN Oncology · 2013
  19. CD79B and MYD88 Mutations in Splenic Marginal Zone LymphomaISRN Oncology · 2013
  20. The Biology of Ewing SarcomaISRN Oncology · 2013
  21. A Multisource Approach to Improving Epidemiologic Estimates: Application to Global B-Cell MalignanciesISRN Oncology · 2012
  22. Epidemiological Characteristics of Cancer in Elderly ChineseISRN Oncology · 2012
  23. The Pak4 Protein Kinase in Breast CancerISRN Oncology · 2012
  24. The Potential Benefit by Application of Kinetic Analysis of PET in the Clinical OncologyISRN Oncology · 2012
  25. Trends in Kaposi’s Sarcoma in Miami Beach from 1987 to 2007ISRN Oncology · 2012
  26. Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast CancerISRN Oncology · 2012
  27. The Role of Radiotherapy and Chemotherapy in the Treatment of Primary Adult High Grade Gliomas: Assessment of Patients for These Treatment Approaches and the Common Immediate Side EffectsISRN Oncology · 2012
  28. Immunotherapy of Malignant Disease Using Chimeric Antigen Receptor Engrafted T CellsISRN Oncology · 2012
  29. Evaluation of Acute Locoregional Toxicity in Patients with Breast Cancer Treated with Adjuvant Radiotherapy in Combination with PazopanibISRN Oncology · 2012
  30. The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of LymphosarcomaISRN Oncology · 2012
  31. Diagnostic Role of 18F-FECH-PET/CT Compared with Bone Scan in Evaluating the Prostate Cancer Patients Referring with Biochemical RecurrenceISRN Oncology · 2012
  32. Molecular Profiles of Pre- and Postoperative Breast Cancer Tumours Reveal Differentially Expressed GenesISRN Oncology · 2012
  33. Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast CancerISRN Oncology · 2012
  34. Development of Safer Gene Delivery Systems to Minimize the Risk of Insertional Mutagenesis-Related Malignancies: A Critical Issue for the Field of Gene TherapyISRN Oncology · 2012
  35. Carbonic Anhydrase I as a New Plasma Biomarker for Prostate CancerISRN Oncology · 2012
  36. Serum Adiponectin Level and Different Kinds of Cancer: A Review of Recent EvidenceISRN Oncology · 2012
  37. General Aspects of Colorectal CancerISRN Oncology · 2012
  38. Preparation of99mTc-Clomiphene Citrate as a Novel Agent for Breast Cancer ImagingISRN Oncology · 2012
  39. Bone Scan Is of Doubtful Value as a First Staging Test in the Primary Presentation of Prostate CancerISRN Oncology · 2012
  40. Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and TherapyISRN Oncology · 2012
  41. Inflammatory Malignant Fibrous Histiocytoma Associated with Leukemoid Reaction or Leukocytosis: A Comprehensive ReviewISRN Oncology · 2012
  42. The Dynamic Optical Breast Imaging in the Preoperative Workflow of Women with Suspicious or Malignant Breast Lesions: Development of a New Comprehensive ScoreISRN Oncology · 2012
  43. Risk of Cancer Mortality in Spanish Towns Lying in the Vicinity of Pollutant IndustriesISRN Oncology · 2012
  44. Ovarian Reserve in Women Treated for Acute Lymphocytic Leukemia or Acute Myeloid Leukemia with Chemotherapy, but Not Stem Cell TransplantationISRN Oncology · 2012
  45. Assessment of Ondansetron-Associated Hypokalemia in Pediatric Oncology PatientsISRN Oncology · 2012
  46. Primary Gastric Lymphoma: Conservative Treatment Modality Is Not Inferior to Surgery for Early-Stage DiseaseISRN Oncology · 2012
  47. Safe Removal of the Urethral Catheter 2 Days Following Laparoscopic Radical ProstatectomyISRN Oncology · 2012
  48. The Opposing Roles of Cellular Inhibitor of Apoptosis Proteins in CancerISRN Oncology · 2012
  49. The Stemness Phenotype ModelISRN Oncology · 2012
  50. Oropharyngeal Cancer Survival: A Population-Based Study of Patients Diagnosed between 1978 and 2002ISRN Oncology · 2012